更选择性动静脉内瘘策略对血管通路结局的影响
一项实用观察性研究纳入692例以中心静脉导管起始血透的患者,比较最大化AVF(期1,408例)与避免高危AVF(期2,284例)两种策略。期2初始AVG比例更高(41% vs 28%),期2中AVF患者的手术频率和费用低于AVG患者,总费用期2低于期1。
要点
- 期2初始AVG比例显著高于期1(41% vs 28%)。
- 期1中AVF患者年费用高于AVG患者($10,642 vs $6810),期2中AVF患者低于AVG患者($5481 vs $8253)。
- 期1中AVF患者导管依赖年数三倍于AVG患者(23.3 vs 8.1),期2仅高30%(20.8 vs 16.0)。
核心结论
- 更选择性的AVF放置策略降低了血管通路手术频率和通路管理成本。
研究设计与样本
- 实用观察性研究,纳入692例以CVC起始血透后接受AVF或AVG的患者;期1(2004-2012年)408例采用最大化AVF策略,期2(2013-2019年)284例采用避免高危AVF策略。
主要发现
- 期2初始AVG放置比例显著高于期1(41% vs 28%)。
- 期1中初始AVF患者每100患者年所有通路手术频率显著高于AVG患者,期2中则显著低于AVG患者。
- 期1中AVF患者年中位通路管理成本显著高于AVG患者($10,642 vs $6810),期2中AVF患者显著低于AVG患者($5481 vs $8253)。
- 期1中AVF患者每100患者年导管依赖年数为AVG患者的三倍(23.3 vs 8.1),期2中仅高30%(20.8 vs 16.0)。
- 所有患者汇总,期2年中位通路管理成本显著低于期1($6757 vs $9781)。
临床怎么用
- 临床医生应更选择性地放置AVF,因为该方法改善血管通路结局。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SIGNIFICANCE STATEMENT: The optimal choice of vascular access for patients undergoing hemodialysis-arteriovenous fistula (AVF) or arteriovenous graft (AVG)-remains controversial. In a pragmatic observational study of 692 patients, the authors found that among patients who initiated hemodialysis with a central vein catheter (CVC), a strategy that maximized AVF placement resulted in a higher frequency of access procedures and greater access management costs for patients who initially received an AVF than an AVG. A more selective policy that avoided AVF placement if an AVF was predicted to be at high risk of failure resulted in a lower frequency of access procedures and access costs in patients receiving an AVF versus an AVG. These findings suggest that clinicians should be more selective in placing AVFs because this approach improves vascular access outcomes. BACKGROUND: The optimal choice of initial vascular access-arteriovenous fistula (AVF) or graft (AVG)-remains controversial, particularly in patients initiating hemodialysis with a central venous catheter (CVC). METHODS: In a pragmatic observational study of patients who initiated hemodialysis with a CVC and subsequently received an AVF or AVG, we compared a less selective vascular access strategy of maximizing AVF creation (period 1; 408 patients in 2004 through 2012) with a more selective policy of avoiding AVF creation if failure was likely (period 2; 284 patients in 2013 through 2019). Prespecified end points included frequency of vascular access procedures, access management costs, and duration of catheter dependence. We also compared access outcomes in all patients with an initial AVF or AVG in the two periods. RESULTS: An initial AVG placement was significantly more common in period 2 (41%) versus period 1 (28%). Frequency of all access procedures per 100 patient-years was significantly higher in patients with an initial AVF than an AVG in period 1 and lower in period 2. Median annual access management costs were significantly higher among patients with AVF ($10,642) versus patients with AVG ($6810) in period 1 but significantly lower in period 2 ($5481 versus $8253, respectively). Years of catheter dependence per 100 patient-years was three-fold higher in patients with AVF versus patients with AVG in period 1 (23.3 versus 8.1, respectively), but only 30% higher in period 2 (20.8 versus 16.0, respectively). When all patients were aggregated, the median annual access management cost was significantly lower in period 2 ($6757) than in period 1 ($9781). CONCLUSIONS: A more selective approach to AVF placement reduces frequency of vascular access procedures and cost of access management.
引用
- Allon M, Al-Balas A, Young CJ, et al. Effects of a More Selective Arteriovenous Fistula Strategy on Vascular Access Outcomes. J Am Soc Nephrol. 2023. PMID: 37401775. doi:10.1681/ASN.0000000000000174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。